Clene

CLNN

Market cap $95.3M

8.09 USD

+1.95

31.76%

At close Updated May 4, 4:00 PM EDT

Pre-market

After hours

7.81

-0.28

3.46%

1 day

31.76%

5 days

33.94%

1 month

40.45%

3 months

102.76%

6 months

-25.92%

Year to date

40.21%

1 year

178.01%

5 years

-95.46%

10 years

-95.81%

About: Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Employees: 79

Consumer Staples Packaged Foods